This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

November 2-4, 2020
Hilton San Francisco Union Square,
San Francisco, CA

CAR and T Cell Therapies: Pioneering point of care with innovative manufacturing and commercialization strategies

Revolutionizing cell engineering - ground breaking autologous and allogeneic treatments for blood borne and solid tumors

Next Generation CAR & T Cell Therapies Has Been Rescheduled to November 2-4, 2020

Our team is pleased to announce that Next Generation CAR & T Cell Therapies is now rescheduled for November 2-4, 2020 at the Hiton Union Square, in San Francisco, CA.

We truly appreciate the outpouring of positive feedback received from our customers and colleagues within the Next Generation CAR & T Cell Therapies community. Rescheduling an event comes with challenges, but the safety and experience of everyone involved is our top priority and we’re committed to following the guidance of the local authorities.

Here's what the rescheduled event means for you:

Attendees: Your registration will automatically carry over to the new dates and you do not need to re-register. Should you have any questions, please contact our customer service team at register@informaconnect.com.

Speakers: Over the next few days our production team will contact you to reconfirm your participation as a speaker during our rescheduled dates.

Sponsors and Exhibitors: All contracts will be automatically applied to the new dates, leaving all Exhibit spaces and Sponsorship the same as originally contracted.

We wish to thank those who participate in, and support, Next Generation CAR & T Cell Therapies and we greatly appreciate your patience and understanding.

Next Generation Technologies and Success Strategies….

Solid Tumours, Reducing Toxicity, Tackling Persistence & Enhancing Efficacy
  • Get to grips with solid tumour microenvironments and improving CAR function & potency
  • Exchange ideas on alternatives to CAR-T: CAR-NK, Gamma Delta T and TCR Therapies
  • Work towards better safety and efficacy with cytokine modulation and more…
Novel Gene Editing Applications in CART – PLUS NEW dedicated Gene Editing Track!
  • Understand next generations technologies in adoptive T cell immunotherapy
  • Prepare for allo CAR & T Cell Therapies – iPSc, Gene editing & highly characterized products
  • Build controls for product quality & specifications around gene editing
Automation & Process Development Strategies for Auto and Allo Cell Therapies
  • Prepare for commercialization with evolution in automation approaches
  • Streamline manufacturing to reduce CoGs and reduce turnaround time
  • Simplify manufacturing concepts for ‘off-the-shelf’ cell therapies

Which one would you consider yourself to be....?

I am a Pioneer

- An innovator who has been in the industry since conception and wants to put theory into practice

Why should I attend?

- Learn about the progression and commercialization of cell and gene therapies

- Hear from small emerging biotech's such as Baylor College of Medicine, Eureka Therapeautics, Triumriva Immunologics, Inc who are pitching big ideas

- Benchmark, network & meet peers and tech providers through the one-to-one meeting tool

I am STILL LEARNING

- Fairly new to the cell and gene therapy community with previous experience with MAb's and other modalities

Why should I attend?

- Hear how the industry think to apply my experience in the space

- Understand the industry landscape and where the gaps lie

- Have the opportunity for exposure, collaboration and success

I am a PROBLEM SOLVER

- I bring thought leadership to the table I have a clear definition of what the industry issues are

Why should I attend?

- Get access to all the key stakeholders in industry

- Gain authority in the field through building my personal brand

- Get an unrivaled opportunity to present cutting edge scientific data

Next Generation CAR & T Cell Therapies: 2019 Number Crunching

100+
attendees hit San Francisco in 2019 – Let’s make this year bigger and better
70+
companies represented in 2019 – Were you one of them?
3 DAYS
of in-depth programmes in key areas

PRESENT A SCIENTIFIC POSTER!


Share your company's new research by presenting a poster at Next Generation CAR & T Cell Therapies.  All posters are displayed in the Poster & Exhibit Hall throughout the event.

Please note that all poster presenters must be registered attendees.

Submit Poster Presentation

DEADLINE TO SUBMIT PROPOSALS: MONDAY 25TH MAY 2020

CONNECT WITH KEY BUYERS AT NEXT GENERATION CAR & T CELL THERAPIES 2020 IN SAN FRANCISCO


Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals.  

Contact Kristen Schott: KSchott@informaconnectls.com | +1 857 504 6685

CELL & GENE THERAPY MANUFACTURING DIGITAL WEEK


A week-long series of free webinars with live Q&A continues to connect cell and gene therapy leaders throughout the year from the comfort of your desk, hear the latest updates from leading industry speakers and gain an insight into some of the most innovative topics and research. 


Don't miss out this year's DIGITAL WEEK: 20-23 APRIL 2020

Registration now open